Connection

Alexey Vertegel to Recombinant Fusion Proteins

This is a "connection" page, showing publications Alexey Vertegel has written about Recombinant Fusion Proteins.
Connection Strength

0.028
  1. A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis. Clin Exp Immunol. 2014 Aug; 177(2):500-8.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.